Viewing Study NCT03603366


Ignite Creation Date: 2025-12-24 @ 4:19 PM
Ignite Modification Date: 2026-01-02 @ 1:39 PM
Study NCT ID: NCT03603366
Status: COMPLETED
Last Update Posted: 2020-10-05
First Post: 2018-07-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study to Evaluate How Patients Regard the Benefits and Risks of Low-dose Aspirin for the Prevention of Heart and Blood Vessels Disease and for the Prevention of Cancer of the Colon and Rectum
Sponsor: Bayer
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2019-08-14
Start Date Type: ACTUAL
Primary Completion Date: 2019-10-14
Primary Completion Date Type: ACTUAL
Completion Date: 2019-10-14
Completion Date Type: ACTUAL
First Submit Date: 2018-07-20
First Submit QC Date: None
Study First Post Date: 2018-07-27
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2020-09-30
Last Update Post Date: 2020-10-05
Last Update Post Date Type: ACTUAL